<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000044897">
  <TermName>Biomed 101</TermName>
  <TermPronunciation>(BY-oh-MED â€¦)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A substance that is being studied for its ability to decrease the side effects of interleukin-2 (IL-2).</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000706108" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Biomed 101&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000706107" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Biomed 101&quot;" language="es" id="_4"/>
  <SpanishTermName>Biomed 101</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Sustancia en estudio por su capacidad de disminuir los efectos secundarios de la interleucina-2 (IL-2).</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
</GlossaryTerm>
